Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 121


Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

van der Stap DK, Rider LG, Alexanderson H, Huber AM, Gualano B, Gordon P, van der Net J, Mathiesen P, Johnson LG, Ernste FC, Feldman BM, Houghton KM, Singh-Grewal D, Kutzbach AG, Munters LA, Takken T.

J Rheumatol. 2015 Nov 15. pii: jrheum.150270. [Epub ahead of print]


Gene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases.

Gan L, O'Hanlon TP, Lai Z, Fannin R, Weller ML, Rider LG, Chiorini JA, Miller FW.

PLoS One. 2015 Nov 10;10(11):e0142486. doi: 10.1371/journal.pone.0142486. eCollection 2015.


Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis.

Lintner KE, Patwardhan A, Rider LG, Abdul-Aziz R, Wu YL, Lundström E, Padyukov L, Zhou B, Alhomosh A, Newsom D, White P, Jones KB, O'Hanlon TP, Miller FW, Spencer CH, Yu CY.

Ann Rheum Dis. 2015 Oct 22. pii: annrheumdis-2015-207762. doi: 10.1136/annrheumdis-2015-207762. [Epub ahead of print]


Myositis autoantibodies, clinical features, and environmental exposures at illness onset are associated with disease course in juvenile myositis.

Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S, Pandey JP, Boonacker C, van Brussel M, Miller FW, van Royen-Kerkhof A, Rider LG; Childhood Myositis Heterogeneity Study Group.

Arthritis Rheumatol. 2015 Oct 16. doi: 10.1002/art.39466. [Epub ahead of print]


Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies.

Yao L, Yip AL, Shrader JA, Mesdaghinia S, Volochayev R, Jansen AV, Miller FW, Rider LG.

Rheumatology (Oxford). 2015 Sep 27. pii: kev344. [Epub ahead of print]


Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.

Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM, Pachman LM, Reed AM, Rider LG, Cobb J, Platt H, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker J, De Paepe B, Maurer B, Ollier WE, Padyukov L, O'Hanlon TP, Lee A, Amos CI, Gieger C, Meitinger T, Winkelmann J, Wedderburn LR, Chinoy H, Lamb JA; Myositis Genetics Consortium.

Ann Rheum Dis. 2015 Sep 11. pii: annrheumdis-2015-208119. doi: 10.1136/annrheumdis-2015-208119. [Epub ahead of print]


Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.

Artlett CM, Sassi-Gaha S, Ramos RC, Miller FW, Rider LG.

Arthritis Res Ther. 2015 Sep 4;17:238. doi: 10.1186/s13075-015-0732-0.


Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Miller FW, Chen W, O'Hanlon TP, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WE, Scheet P, Peng B, Lee A, Byun J, Lamb JA, Gregersen PK, Amos CI.

Genes Immun. 2015 Oct;16(7):470-80. doi: 10.1038/gene.2015.28. Epub 2015 Aug 20.


Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?

Wing S, Rider LG, Johnson JR, Miller FW, Matteson EL, Crowson CS, Gabriel SE.

BMJ Open. 2015 May 15;5(5):e006636. doi: 10.1136/bmjopen-2014-006636.


The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG.

Curr Rheumatol Rep. 2014 Dec;16(12):467. doi: 10.1007/s11926-014-0467-y. Review.


Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.

Rider LG, Dankó K, Miller FW.

Curr Opin Rheumatol. 2014 Nov;26(6):724-41. doi: 10.1097/BOR.0000000000000119. Review.


Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Rider LG, Yip AL, Horkayne-Szakaly I, Volochayev R, Shrader JA, Turner ML, Kong HH, Jain MS, Jansen AV, Oddis CV, Fleisher TA, Miller FW.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):689-96. Epub 2014 Jul 28.


Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.

Gan L, O'Hanlon TP, Gordon AS, Rider LG, Miller FW, Burbelo PD.

BMC Musculoskelet Disord. 2014 Mar 6;15:67. doi: 10.1186/1471-2474-15-67.


Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.

Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC; RIM Study Group, Oddis CV.

Arthritis Rheumatol. 2014 Mar;66(3):740-9. doi: 10.1002/art.38270.


Confusion concerning multiple versions of the childhood myositis assessment scale.

Huber AM, Lovell DJ, Pilkington CA, Rennebohm RM, Rider LG.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):648. doi: 10.1002/acr.22239. No abstract available.


Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Rider LG, Katz JD, Jones OY.

Rheum Dis Clin North Am. 2013 Nov;39(4):877-904. doi: 10.1016/j.rdc.2013.06.001. Epub 2013 Sep 19. Review.


Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2014 May;66(5):732-40. doi: 10.1002/acr.22212.


Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes.

Razzaghian HR, Forsberg LA, Prakash KR, Przerada S, Paprocka H, Zywicka A, Westerman MP, Pedersen NL, O'Hanlon TP, Rider LG, Miller FW, Srutek E, Jankowski M, Zegarski W, Piotrowski A, Absher D, Dumanski JP.

PLoS One. 2013 Sep 4;8(9):e67752. doi: 10.1371/journal.pone.0067752. eCollection 2013.


Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

Miller FW, Cooper RG, Vencovský J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WE, O'Hanlon TP, Peng B, Lee A, Lamb JA, Chen W, Amos CI, Gregersen PK; Myositis Genetics Consortium.

Arthritis Rheum. 2013 Dec;65(12):3239-47. doi: 10.1002/art.38137.


Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.

Mamyrova G, Katz JD, Jones RV, Targoff IN, Lachenbruch PA, Jones OY, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):1969-75. doi: 10.1002/acr.22088.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk